Acutus Medical, Inc. ( (AFIB)) has released its Q3 earnings. Here is a breakdown of the information Acutus Medical, Inc. presented to its investors. Don't Miss our Black Friday Offers: Acutus ...

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.

View upcoming earnings forecasts and in-depth analysis of company forecasts.

300558.SZ Betta Pharmaceuticals Co., Ltd.

At close: November 19 at 2:31 PM EST ...

Cash, cash equivalents, marketable securities and restricted cash were $12.6 million as of September 30, 2024. Acutus is focused on the production of left-heart access products under its distribution ...

CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended ...

Third Quarter 2024 Financial ResultsRevenue from Continuing Operations was $5.3 million for the third quarter of 2024, an increase of 156% compared to $2.1 million for the third quarter of 2023 ...

We currently have no AFIB Stock Split History on this stock.